Very-early-onset Inflammatory Bowel Disease in an Infant with a Partial <i>RIPK1</i> Deletion
JOURNAL OF CLINICAL IMMUNOLOGY, vol.44, no.5, 2024 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 44 Issue: 5
- Publication Date: 2024
- Doi Number: 10.1007/s10875-024-01707-8
- Journal Name: JOURNAL OF CLINICAL IMMUNOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, Veterinary Science Database
- Keywords: Immunodefciency, Inflammation, Very-early Onset Inflammatory Bowel Disease
- Ankara University Affiliated: Yes
Abstract
The monogenic causes of very-early-onset inflammatory bowel disease (VEO-IBD) have been defined by genetic studies, which were usually related to primary immunodeficiencies. Receptor-interacting serine/threonine-protein kinase-1 (RIPK1) protein is an important signalling molecule in inflammation and cell death pathways. Its deficiency may lead to various clinical features linked to immunodeficiency and/or inflammation, including IBD. Here, we discuss an infant with malnutrition, VEO-IBD, recurrent infections and polyathritis who has a homozygous partial deletion in RIPK1 gene.